Can anyone suggest why the FDA are being so slow in their response regards the p3 trials. It always appeared that it would be a clear cut decision to give the go ahead and yet here they are taking a long time to make a decision , given PAR has fast track designation.
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
41.3¢ |
Change
0.013(3.13%) |
Mkt cap ! $165.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 39.5¢ | $94.19K | 232.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 43018 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 19750 | 1 |
View Market Depth
| Last trade - 10.53am 22/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |